Allogene Therapeutics’ (ALLO) Buy Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group reaffirmed their buy rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a ...
Canaccord Genuity Group Cuts Bird Construction (TSE:BDT) Price Target to C$35.00
Bird Construction (TSE:BDT – Free Report) had its price target decreased by Canaccord Genuity Group from C$36.00 to C$35.00 in a report released on Friday,BayStreet.CA reports. Canaccord Genuity Group ...
Canaccord Genuity Remains a Buy on Prospect Resources Ltd. (PSC)
Canaccord Genuity analyst Timothy Hoff maintained a Buy rating on Prospect Resources Ltd. (PSC – Research Report) yesterday and set a price ...
Canaccord Genuity drops Capital to 'hold', slashes target price
Analysts at Canaccord Genuity slashed their target price on mining services firm Capital from 130.0p to 60.0p on Tuesday and ...
Nasdaq2d
Canaccord Genuity Upgrades Peloton Interactive (LSE:0A46)
Fintel reports that on March 14, 2025, Canaccord Genuity upgraded their outlook for Peloton Interactive (LSE:0A46) from Hold to Buy. There are 652 funds or institutions reporting positions in ...
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to ...
More public market insider buying at Canaccord Genuity Group (CF)
CG Partners Limited Partnership, a 10% Holder, acquired 18,000 Common Shares on an indirect ownership basis for registered holder Canaccord Genuity Corp. at a price of $8.420 on March 12th, 2025. This ...
Snowflake target raised at Canaccord ahead of earnings
Canaccord Genuity raised its price target on Snowflake (NYSE:SNOW) by $30 to $220, as company is set to report fourth-quarter earnings on Wednesday. Stabilizing growth and AI-driven expansion are key ...